Brief: Synact Pharma Gets SEK 17.7 Mln After Second Warrant Conversion
Aug 15 (Reuters) - SynAct Pharma AB SYNACT.ST: TO RECEIVE SEK 17.7 MILLION AFTER SECOND CONVERSION OF WARRANTS OUTSTANDING WARRANTS NOW 1,375,000 Source text: ID:nMFN3JnfH0 Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development